Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 57

1.

QT interval variability and spontaneous ventricular tachycardia or fibrillation in the Multicenter Automatic Defibrillator Implantation Trial (MADIT) II patients.

Haigney MC, Zareba W, Gentlesk PJ, Goldstein RE, Illovsky M, McNitt S, Andrews ML, Moss AJ; Multicenter Automatic Defibrillator Implantation Trial II investigators.

J Am Coll Cardiol. 2004 Oct 6;44(7):1481-7.

3.

New primary prevention trials of sudden cardiac death in patients with left ventricular dysfunction: SCD-HEFT and MADIT-II.

Klein H, Auricchio A, Reek S, Geller C.

Am J Cardiol. 1999 Mar 11;83(5B):91D-97D. Review.

PMID:
10089848
5.

QT Variability Index.

Dobson CP, Kim A, Haigney M.

Prog Cardiovasc Dis. 2013 Sep-Oct;56(2):186-94. doi: 10.1016/j.pcad.2013.07.004. Epub 2013 Oct 4. Review.

PMID:
24215750
6.
7.

What risk should justify implantable cardioverter defibrillator therapy?

Schläpfer J, Kappenberger L, Fromer M.

Am J Cardiol. 1999 Mar 11;83(5B):101D-103D. Review.

PMID:
10089850
10.

The dilemma of ICD implant testing.

Swerdlow CD, Russo AM, Degroot PJ.

Pacing Clin Electrophysiol. 2007 May;30(5):675-700. Review.

PMID:
17461879
12.

Indications for an implantable cardioverter defibrillator (ICD).

Aizawa Y, Chinushi M, Washizuka T.

Intern Med. 2004 May;43(5):360-7. Review.

13.

[Indications of automatic ventricular implantable defibrillator. Implications for daily practice].

Leclercq JF.

Ann Cardiol Angeiol (Paris). 2001 Oct;50(6):319-25. Review. French.

PMID:
12555623
14.

Role of implantable cardioverter defibrillator therapy in the management of high-risk patients.

Akhtar M, Avitall B, Jazayeri M, Tchou P, Troup P, Sra J, Axtell K.

Circulation. 1992 Jan;85(1 Suppl):I131-9. Review.

PMID:
1728496
15.

Direct operation versus ICD therapy for ischemic ventricular tachycardia.

Ferguson TB Jr, Smith JM, Cox JL, Cain ME, Lindsay BD.

Ann Thorac Surg. 1994 Oct;58(4):1291-6. Review.

PMID:
7944809
16.

An overview of the fifth-generation implantable cardioverter defibrillator.

Tanaka S.

Ann Thorac Cardiovasc Surg. 1998 Dec;4(6):303-11. Review.

PMID:
9914457
17.

Drug therapy for ventricular tachyarrhythmia in heart failure.

Shiga T, Kasanuki H.

Circ J. 2007;71 Suppl A:A90-6. Review.

18.

Treatment of ventricular arrhythmias after recovery from myocardial infarction.

Mitchell LB.

Annu Rev Med. 1994;45:119-38. Review.

PMID:
7515218
19.

A review of the implantable cardioverter defibrillator trials.

Cannom DS.

Curr Opin Cardiol. 1998 Jan;13(1):3-8. Review.

PMID:
9559251
20.

Arrhythmias and left ventricular hypertrabeculation /noncompaction.

Stöllberger C, Finsterer J.

Curr Pharm Des. 2010;16(26):2880-94. Review.

PMID:
20632950

Supplemental Content

Support Center